GC081 Seizure And Loss Of Consciousness Delirium And Encephalopathy; Epilepsy; Coma And Brain Death; Care Of Unconscious Patients; Electrophysiology I

A clinical spectrum encompassing seizures, epilepsy, delirium, encephalopathy, coma, and brain death, representing varying degrees of altered consciousness due to abnormal cerebral electrical activity or diffuse brain dysfunction, assessed and characterized through electrophysiological studies such as electroencephalography (EEG).

Seizure and Loss of Consciousness: Delirium & Encephalopathy; Epilepsy; Coma & Brain Death; Care of Unconscious Patients; Electrophysiology I

This GC 081 lecture by Dr. Kay-Cheong Teo is a foundational neurology lecture that ties together multiple high-yield exam topics under one umbrella: why do patients lose consciousness, and what do you do about it? [1]

The Big Idea: Consciousness requires two intact systems working together — the brainstem reticular activating system (arousal) and the cerebral cortex (awareness). When either or both fail — whether from structural damage, metabolic derangement, seizure activity, or hemodynamic collapse — the patient presents with altered consciousness. Your job is to figure out which system failed, why it failed, and how urgently you need to act.

Learning Objectives (directly from slides) [1]:

  1. Describe the differential diagnosis and management of altered state of consciousness
  2. Perform the Glasgow Coma Scale (GCS)
  3. Identify features that differentiate syncope and seizure
  4. Name the different classifications of seizure
  5. Explain the definition of seizure and epilepsy
  6. Describe the epidemiology, etiologies, and clinical features of common seizure/epilepsy types
  7. Describe commonly used antiseizure medications and their side effects
  8. Learn emergency management of seizure attack and status epilepticus
  9. Recognize the value of EEG as an investigative tool
  10. Explain what brain death is and how it is diagnosed

Exam Fit: This lecture is heavily examined in MCQ (syncope vs. seizure differentiation, ASM side effects, GCS calculation, brain death criteria) and SAQ/minicase (status epilepticus management, first seizure workup, epilepsy classification). Past papers consistently test GCS calculation, syncope vs. seizure discrimination, status epilepticus protocol, and ASM choice in specific patient populations. [10][11]


Part 1: Consciousness and Its Disorders

Consciousness = state of awareness of self and environment. It has two components: Arousal (brainstem function — reticular activating system) and Awareness (high-level integration of multiple sensory inputs — resides in the cerebral cortex). [1]

Think of it as a two-layer system:

  • Arousal = the "power switch" — is the brain turned on? This is a primitive brainstem function controlled by the ascending reticular activating system (ARAS).
  • Awareness = the "software" — can the brain process and integrate information? This resides in the cerebral cortex.

You need BOTH for normal consciousness. Damage to either can produce different clinical states.

The reticular formation is a complex network of brainstem nuclei and neurons spanning the entire brainstem. [1]

SystemFunction
Ascending reticular activating systemArousal / consciousness
Descending reticular systemMuscle tone, autonomic nervous system / visceral function

How the ARAS maintains consciousness [1]:

  • Sensory and visceral inputs converge on the brainstem reticular formation, which projects through the thalamus to widespread cortex; this broad projection explains why a small strategic brainstem lesion can impair arousal profoundly
  • Thalamic relay neurons activate cortical pyramidal neurons, while the descending reticular system influences tone and autonomic function
  • Tonic mode (desynchronized firing) → wakefulness or REM sleep
  • Burst mode (rhythmic, bilateral synchronous firing) → non-REM sleep (produces sleep spindles on EEG)

Why this matters: A lesion in the brainstem (e.g., basilar artery stroke) can knock out the ARAS and produce coma, even though the cortex itself is undamaged. Conversely, diffuse cortical damage (e.g., from hypoxia) can abolish behavioural evidence of awareness while leaving arousal intact—a pattern seen in VS/UWS. [2][12]

A same condition, e.g. stroke, can result in any of these states depending on the location and severity. [1]

ConditionAwarenessSleep-Wake CycleMotor Behavior
ComaNoNoNo purposeful behavior; posturing to pain
Vegetative state / unresponsive wakefulness syndrome (VS/UWS)No behavioural evidenceYesNo purposeful behavior; spontaneous eye opening; reflexive/random vocalization
Minimally conscious state (MCS)Definite but partial/fluctuating evidenceYesInconsistent but reproducible purposeful behavior: command following, localization or visual pursuit
Locked-in syndrome (mimics DOC)YesYesQuadriplegia/anarthria; vertical eye movements and blinking are classically preserved
Altered mental state / delirium——Any acute change in attention/awareness or cognition

Exam Trap: Locked-In Syndrome

Locked-in syndrome is NOT a disorder of consciousness—the patient is fully aware but has quadriplegia and anarthria due to damage of descending motor tracts in the brainstem (classically basilar artery occlusion affecting the ventral pons). In the classic form, communication is through preserved vertical eye movements and blinking. Do not confuse it with coma or VS/UWS. [1][2]

Key discriminators for exams:

  • Coma vs. VS/UWS: VS/UWS has sleep-wake cycles (eyes open periodically) but no behavioural evidence of awareness
  • VS/UWS vs. MCS: MCS shows reproducible purposeful behavior (e.g., visual pursuit, localizing to pain)
  • Locked-in syndrome: Full awareness, vertical eye movements preserved — test by asking patient to blink

Terminology and Bedside Caution

The slide uses the older terms “vegetative state” and “minimal conscious state.” Current guidance pairs vegetative state with unresponsive wakefulness syndrome (VS/UWS) and uses minimally conscious state (MCS). A single bedside examination can miss fluctuating responses; use repeated, standardized assessment and actively exclude locked-in syndrome. [12]

1.4 Causes of Altered State of Consciousness / Coma

The lecture divides causes into two broad categories [1]:

Damage to reticular formation OR sizable/diffuse lesion [1]

  • Stroke (ischemic/hemorrhagic)
  • Traumatic brain injury / epidural / subdural hematoma
  • Brain mass / tumor
  • CNS infection
  • Inflammation (autoimmune encephalitis)
  • Hydrocephalus

Encephalopathy = group of conditions that lead to brain dysfunction [1]

CategoryExamples
SepsisSeptic encephalopathy
Electrolyte disturbanceHyponatremia, hypercalcemia
Hypo/hyperglycemiaAlways check fingerstick glucose first
Renal failureUremic encephalopathy
Liver failureHepatic encephalopathy
Wernicke encephalopathyThiamine deficiency (alcoholics, malnutrition)
EndocrineAdrenal crisis, thyroid storm, myxedema coma
ToxicAlcohol, substance abuse
Seizure / Status epilepticusElectrical abnormalities
Cerebral hypoperfusion / hypoxiaSyncope, shock

High Yield: Always Check Glucose

Hypoglycemia is a rapidly reversible cause of altered consciousness. Check bedside glucose immediately and treat clinically important hypoglycemia without delay according to the local emergency protocol. Give parenteral thiamine promptly before or alongside carbohydrate when Wernicke encephalopathy is suspected or the patient is at high nutritional risk, but do not delay glucose while waiting for thiamine. [3][13]

History to identify potential cause. PE: ABC → GCS → Pupillary reflexes → Obvious focal weakness → Plantar responses → Any trauma → Fever → Neck stiffness [1]

The order matters: ABC first (airway, breathing, circulation), then neurological assessment. This is your "30-second survey."

GCS 13-15: Mild | 9-12: Moderate | 3-8: Severe [1]

ComponentScoreResponse
Eye Opening (E)4Spontaneous
3To speech
2To pain
1None
Verbal Response (V)5Orientated
4Confused (sentences but disoriented)
3Inappropriate words
2Incomprehensible sounds
1None
Motor Response (M)6Obeys commands
5Localizes to pain
4Flexion withdrawal
3Abnormal flexion (decorticate)
2Extension (decerebrate)
1None

Total range: 3–15

GCS Calculation — Past Paper Example

From 2019 SAQ Q8: "A 68-year-old woman... open eyes to painful stimuli (E2), flex limbs to painful stimuli (M4 — flexion withdrawal), utter inappropriate words (V3)." → GCS = 2 + 3 + 4 = 9 (Moderate). Always break it down as E_V_M and state the total. [10]

Clinical pearls for GCS:

  • Always record the best response
  • A low GCS should trigger urgent airway assessment, but GCS alone does not prove inability to protect the airway; intubate when airway protection, ventilation or oxygenation is inadequate, using the whole clinical picture
  • Elicit pain at supraorbital ridge, earlobe, or trapezius squeeze — avoid sternal rub (bruising) [2]
  • Localizing to pain (M5): hand comes up above the clavicle toward the stimulus
  • Flexion withdrawal (M4): elbow flexes but hand does NOT cross the clavicle
  • Abnormal flexion/decorticate (M3): internal rotation + pronation + shoulder adduction ± spastic wrist flexion
  • Extension/decerebrate (M2): elbow extension + shoulder adduction

Blood/urine tests (routines, glucose, toxins/drug screen), Neuroimaging (based on clinical suspicion), Lumbar puncture, EEG [1]

Supportive: ABC; intubate when airway protection, oxygenation or ventilation is inadequate. Specific management depends on the cause identified. [1]


Part 2: Transient Loss of Consciousness — Syncope vs. Seizure

This is one of the most heavily examined topics in this lecture.

Loss of consciousness with complete recovery. Syncope (cardio or cerebrovascular cause) vs. Seizure. History from witness is vital. [1]

LOC + muscle jerk does NOT mean seizure. Syncopal myoclonus occurs in up to 20% of patients with syncope. [1]

CRITICAL Exam Point: Misdiagnosis Kills

Misdiagnosing seizure and missing cardiovascular syncope → Mortality of cardiovascular syncope is much HIGHER than seizure. [1] This is a favorite exam stem: a patient with "convulsion" who actually had cardiac syncope with syncopal myoclonus. The 1-year mortality of cardiac syncope far exceeds epilepsy. Always consider cardiac causes before labeling "seizure."

ClassificationRemarks
Neurocardiogenic (most common)Increased vagal tone — vasovagal syncope, situational syncope (micturition/defecation)
Cardiac (most lethal)MI, arrhythmia, valvular heart disease, cardiac tamponade, PE
Neurological mimicsSeizure; very rarely posterior-circulation ischaemia with focal neurological features. These are not mechanisms of true syncope
OrthostaticSustained fall in systolic BP ≥20 mmHg or diastolic BP ≥10 mmHg after standing (classically within 3 minutes) — drugs, volume loss, autonomic dysfunction [14]
UnknownNeed to rule out potential life-threatening causes

The visual hierarchy is the clinical lesson: reflex syncope is common, but cardiac syncope is the dangerous diagnosis not to miss. Obtain a 12-lead ECG and look for exertional/supine events, structural heart disease, family history of sudden death, chest pain or palpitations; jerks do not make the episode epileptic.

This table is directly from the lecture slides and is extremely high yield [1]:

FeatureCardiogenic SyncopeSeizure
Preceding lightheadedness/sweating++-
Chest pain / Palpitation++/-
Situational (crowded/hot place, micturition)++- (flashing lights for seizure)
Postural change++-
DurationSeconds to minutesMinutes
Limb twitchingAfter LOC, few secondsOccurs WITH LOC, at least 30-60 seconds
Urinary incontinence++
Tongue or lip injury+ (through injury from fall)++ (lateral tongue bite is classic for seizure)
Post-eventDrowsy but not confused; orientated within minutesDrowsiness/confusion up to hours (postictal)
Family history++/-
1-year mortalityHIGHLow

High Yield Discriminator

The two best discriminators between syncope and seizure from this table are: (1) Timing of limb twitching — in syncope, jerking occurs AFTER LOC and lasts only seconds; in seizure, it occurs WITH LOC and lasts ≥30-60 seconds. (2) Postictal state — seizure patients have prolonged drowsiness/confusion (hours); syncope patients recover rapidly and are oriented within minutes. [1]


Part 3: Seizure and Epilepsy

Seizure: Sudden burst of electrical activity in the brain leading to changes in movement, behavior, feeling and/or consciousness. [1]

Diagnosis of seizure: CAREFUL HISTORY IS MOST IMPORTANT. Suggestive features: transient occurrence of abnormal behavior, involuntary movements, recurrent/stereotypical attack. [1]

Epilepsy: Brain disorder that causes recurring, unprovoked seizures. [1]

Abnormal synchronous brain activity caused by abnormal spread & neuronal recruitment secondary to: (1) Enhanced excitatory transmission, (2) Failure of inhibitory mechanism, (3) Changes in intrinsic neuronal properties. [1]

In simple terms: neurons that normally fire independently get "recruited" into synchronized, self-sustaining bursts of activity. This can happen because excitation (glutamate) is too high, inhibition (GABA) is too low, or the neurons themselves have abnormal membrane properties (e.g., ion channel mutations).

This is a classic exam topic — "what else could it be?" [1]

MimicKey Distinguishing Features
Panic attack / HyperventilationAbrupt intense dread/fear; sense of impending death; prominent autonomic features (sweating, tachycardia, nausea); external trigger; longer (5-30 min); may have perioral/hand numbness, carpopedal spasm
Psychogenic non-epileptic seizure (PNES)Psychiatric history; patient motionless with eyes CLOSED at onset; fluttering eye movements and FORCEFUL eye closure; out-of-phase, thrashing limb movements and pelvic thrusting; urinary incontinence unusual
Syncope(As above)
Transient global amnesiaProminent anterograde amnesia; prolonged duration (hours); NO altered consciousness, confusion, weakness or speech problems; repeated questioning
TIANegative symptoms predominate (weakness, loss of sensation, aphasia)
Migraine auraBoth positive AND negative symptoms (mostly visual/sensory); lasts longer; slow spread of positive symptoms followed by negative symptoms; headache develops AFTER aura

PNES vs. True Seizure — Exam Discriminators

The listed signs (eye closure, asynchronous movements, fluctuating course) may raise suspicion for a functional/dissociative seizure, but no single sign and no psychiatric history establishes the diagnosis; some epileptic seizures have atypical movements, and epilepsy and functional seizures can coexist. Capture a witness video when safe and use specialist assessment with video-EEG of a typical event when diagnostic certainty is needed. Avoid pejorative language or implying that events are voluntary.

3.4 Classification of Seizures

Provoked vs. Unprovoked | Focal vs. Generalized | Etiology [1]

Provoked seizure (acute symptomatic seizure): Seizure due to acute focal/diffuse brain insult. Not epileptic. Residual brain injury may subsequently cause unprovoked seizure (e.g., post-stroke epilepsy). [1]

Unprovoked seizure: Seizure occurring without an acute precipitating factor. Can occur due to static injury (old stroke) or progressing injury (neurodegenerative disease). [1]

Why this distinction matters: Provoked seizures don't necessarily need long-term ASM — treat the underlying cause. Unprovoked seizures raise the question of epilepsy and the need for chronic treatment.

Focal seizures originate in a localized focus. Generalized seizures begin simultaneously in both brain hemispheres. [1]

Classification Update: Slide Era vs Current ILAE

The lecture diagram is the ILAE 2017 framework: focal onset, generalized onset, unknown onset and unclassified, with focal seizures divided by awareness and observable motor/non-motor onset. The 2025 ILAE update retains four main classes—focal, generalized, unknown (whether focal or generalized), and unclassified—but removes “onset” from the class names, uses preserved/impaired consciousness (awareness plus responsiveness) rather than awareness alone, and replaces the motor/non-motor split with observable/non-observable manifestations. Keep the 2017 terms for interpreting this lecture and older exam material, but recognize the newer clinical vocabulary. [15]

3.5 Focal Seizure Symptoms by Lobe

Symptoms depend on the location involved. Serves as "Aura" for focal impaired awareness seizures / generalized seizure. [1]

LobeSymptom
FrontalFocal motor seizure; olfactory hallucination; aphasia; hyperkinetic seizure
TemporalAutonomic (epigastric sensation); cognition (déjà vu / jamais vu); emotional (fear); auditory hallucination
ParietalSomatosensory seizure; visual illusion
OccipitalVisual seizures (flashes / multicolored shapes; loss of visual field)

High Yield: The Epigastric Aura

A rising epigastric sensation is the classic aura of temporal lobe epilepsy. If an exam question describes a patient with an "epigastric rising sensation" followed by behavioral arrest and oral automatisms — think temporal lobe epilepsy with hippocampal sclerosis. [1][4]

Automatism, abnormal posturing, head/eye version. Impaired awareness. [1]

Classical example: Temporal lobe epilepsy due to hippocampal sclerosis — Autonomic (epigastric sensation), cognition (déjà vu/jamais vu) or emotional (fear) seizures followed by behavioral arrest with progressive impaired awareness + automatism (chewing, lip-smacking, swallowing, tongue movement) / mannerism. [1]

Focal seizures can spread to bilateral tonic-clonic seizure (secondary generalization). [1]

TypeFeatures
Tonic-clonicTonic phase → clonic phase; LOC throughout
TonicGeneralized increased tone
MyoclonicBrief, repetitive jerking movements
Non-motor (Absence)Behavioral arrest / impaired consciousness

These four clinical vignettes from the lecture are extremely exam-relevant [1]:

CaseClassification
66/M, acute right frontal stroke, recurrent left arm involuntary movementProvoked seizure (acute injury); focal motor seizure — NOT epilepsy
25/M, recurrent epigastric sensation/déjà vu → behavioral arrest, MRI: hippocampal sclerosisUnprovoked seizure; focal impaired awareness seizure; focal epilepsy (TLE)
18/F, recurrent morning jerks → GTCS, normal MRIUnprovoked; myoclonic + GTCS; generalized epilepsy (JME)
82/F, known dementia → GTCSUnprovoked (progressing injury); generalized epilepsy due to neurodegeneration

At least two unprovoked seizures occurring > 24 hours apart [1]

OR One unprovoked seizure and ≥60% probability of further seizures over the next 10 years [16]

  • Abnormal epileptiform discharges on EEG
  • Structural brain pathology
  • Abnormal neurological examination beyond postictal period (focal findings or intellectual disability)
  • Nocturnal seizure

The third ILAE route is diagnosis of an epilepsy syndrome. A single seizure can therefore lead to an epilepsy diagnosis, but an epileptiform EEG or structural lesion does not automatically cross the ≥60% threshold; risk is individualized to the specific syndrome, lesion and clinical context. Diagnosis and the decision to start long-term treatment are related but distinct. [16]

Incidence has two peaks: (1) Childhood — genetic/polygenetic/unknown, (2) ≥65 years — structural (including neurodegenerative diseases). Prevalence ~1% in adults; in ≥65 years: 2-6%. [1]

The lecture uses a structured etiological framework [1]:

CategoryExamples
GeneticChromosomal (Down, Angelman); Gene (SLC2A1, KCNQ2); mutations in ion channels, NT receptors, synaptic support proteins, mTOR pathway regulators, chromatin remodeling
StructuralDevelopmental: Focal cortical dysplasia, tuberous sclerosis, grey matter heterotopia. Hippocampal sclerosis. Vascular: Stroke, AVM, angioma, hypoxic-ischemic injury. Neoplasm: DNET, primary/secondary brain tumors. Trauma: TBI. Degeneration: Alzheimer's, PD/Lewy body dementia
MetabolicElectrolytes: hypo/hypernatremia, hypocalcemia, hypomagnesemia. Metabolic: hypo/hyperglycemia, uremia, hyperammonemia. Drugs: Tramadol, Carbapenem/Cefepime antibiotics. Substance abuse/alcohol
ImmuneAutoimmune encephalitis (e.g., anti-NMDA receptor)
InfectiousCNS infection
UnknownIdiopathic

Drug-Induced Seizures — Exam Pearls

Tramadol and carbapenem/cefepime antibiotics are specifically listed in the lecture as drugs that cause seizures. This is a favorite MCQ trap. Also remember alcohol WITHDRAWAL (not intoxication) causes seizures. [1]


Part 4: Epilepsy Syndromes

Common cause of temporal lobe seizure. Onset typically adolescent/young adult. [1]

FeatureDetail
CauseAcquired abnormality in hippocampus: loss of pyramidal neurons, granule cell dispersion, gliosis. Contributing factors: genetic, genetic-structural, immune pathology
SeizuresFocal temporal seizures (aware/impaired awareness) — epigastric aura → behavioral arrest → automatisms
EEGAnterior temporal / midtemporal epileptiform discharges
MRIHippocampal sclerosis (atrophy + signal change)
TreatmentAppropriate ASM; often drug-resistant/refractory epilepsy

Common idiopathic generalized epilepsy syndrome. Onset typically 10-24 years, female preponderance. Normal development and cognition. [1]

FeatureDetail
CauseComplex/polygenetic
SeizuresMyoclonic seizures within an hour of waking up → subsequent development of GTCS
EEG3-5.5 Hz spike-wave discharge
MRINormal
TreatmentPhenytoin/carbamazepine may WORSEN myoclonus. Valproate can be highly effective, but reproductive risks and current jurisdiction-specific safety restrictions must be checked; levetiracetam or lamotrigine are common alternatives selected with specialist advice [17]

JME — Classic Exam Scenario

An 18-year-old who keeps dropping a cereal bowl in the morning, then has a GTCS, with normal MRI and generalized spike-wave on EEG, has a classic JME pattern. The exam trap remains: carbamazepine and phenytoin can aggravate myoclonic seizures. Medication choice is individualized; do not turn the lecture's valproate statement into an automatic prescription, particularly where pregnancy is possible. [1][17]

Previously known as epilepsy with grand mal seizure. Onset 10-25 years. Normal development and cognition. Precipitated by sleep deprivation/alcohol. [1]

FeatureDetail
CauseComplex/polygenetic
SeizuresGTCS only
EEG3-5.5 Hz spike-wave discharge
MRINormal
TreatmentSyndrome-appropriate broad-spectrum ASM; reproductive potential, comorbidity and current valproate/topiramate safety measures must be considered [17]

Part 5: Investigations

To detect abnormal electrical activities (epileptiform discharges) in the brain. [1]

The diagnosis of seizure/epilepsy is almost ALWAYS based on clinical history (usually from witness). [1]

Key points from lecture [1]:

  • Around 50% of epilepsy patients have normal interictal EEG → A normal EEG does NOT rule out epilepsy
  • Common to have false positive/borderline positive EEG → overdiagnosis of epilepsy
  • Main uses of EEG:
    1. Support diagnosis of epilepsy
    2. Risk stratification for initiation of ASM
    3. Diagnosis of ongoing seizure / non-convulsive status epilepticus
  • You are NOT expected to know how to interpret EEG, but only know WHEN to order one [1]

EEG patterns mentioned in lecture (for recognition, not interpretation):

  • The cap photograph shows that EEG records voltage differences between scalp electrodes; the displayed channels are a montage, not one trace per brain region
  • The normal example shows an organized background without epileptiform discharges
  • A left temporal epileptiform discharge is maximal over left temporal chains and supports a left temporal epileptogenic tendency; in the illustrated case it fits hippocampal sclerosis
  • A generalized spike-and-wave discharge appears bilaterally synchronous across the montage and supports a generalized epilepsy such as JME
  • Continuous 2 Hz lateralized sharp-and-wave activity and continuous generalized 3-4 Hz spike-and-wave activity illustrate patterns concerning for focal or generalized non-convulsive status, respectively—but EEG criteria require clinical context and expert interpretation

Do not use EEG as a screening test for unexplained blackout or to exclude epilepsy. When the history suggests an epileptic seizure, EEG supports diagnosis and classification; a normal routine EEG may be followed by sleep-deprived or ambulatory EEG if uncertainty persists. [18]

Look for structural lesions. Brain imaging may be normal in many patients. CT is useful acutely; epilepsy-protocol MRI is the preferred structural study when indicated. [1][18]

How to read the slide images [1]:

  • Left frontal meningioma on CT: extra-axial frontal mass with surrounding low-density vasogenic oedema and local mass effect—a plausible structural seizure focus
  • Mesial temporal (hippocampal) sclerosis on coronal T2 MRI: asymmetric hippocampal volume loss, increased T2/FLAIR signal and enlargement of the ipsilateral temporal horn; compare the two hippocampi rather than looking only at the arrow
  • Left frontobasal cavernoma on MRI: a well-circumscribed mixed-signal “popcorn” lesion with a hemosiderin rim; prior microhaemorrhage makes it epileptogenic

Current NICE guidance offers MRI after an epilepsy diagnosis unless the presentation is a typical idiopathic generalized epilepsy or self-limited epilepsy with centrotemporal spikes; CT is an alternative when MRI is contraindicated and remains the practical acute test for haemorrhage or a large mass. [18]

Blood test for electrolytes, glucose, kidney/liver function; further blood test like immune workup/autoimmune encephalitis antibody panel/toxicology screen as appropriate. Lumbar puncture for CSF as appropriate. [1]


Part 6: Management of Seizure/Epilepsy

1. Ensure full recovery (not in status epilepticus). 2. Rule out acute, potentially reversible causes (vascular, infection, inflammation, metabolic, toxic). 3. Make sure it's the FIRST seizure (patient may have recurrent behavioral arrest/myoclonus that family/patient is unaware is relevant). 4. Assess risk of recurrence (epilepsy diagnosis) — EEG/neuroimaging. [1]

Diagnosis of epilepsy has considerable effect on mood, interpersonal relationship, employment, quality of life and ability to drive. [1]

Driving in Hong Kong: epilepsy is a specified condition in the Road Traffic (Driving Licences) Regulations. A licence holder who develops it must notify the Commissioner for Transport in writing; driving fitness/licensing is then an individual legal and medical determination. Do not replace this with the slide's blanket “cannot drive indefinitely” statement, and check the current Transport Department process. [19]

Avoid activities with ↑ risk of injury if seizure occurs: driving, operating high-risk equipment, working at heights, swimming/hiking alone, cooking over fire alone. [1]

Risk of SUDEP (Sudden Unexpected Death in Epilepsy) ~1/1000. Risk reduced with better control of epilepsy. [1]

Used to be known as antiepileptic drugs (AED). Drugs that suppress seizure by changing neurotransmission. [1]

MechanismDrug
Sodium channelCarbamazepine, Lamotrigine, Phenytoin
Calcium currentsEthosuximide
GABA activityBenzodiazepines, Phenobarbital
Glutamate receptorTopiramate
Synaptic vesicle proteinsLevetiracetam

Most act through a primary pathway but also have effect on other pathways. [1]

Broad-spectrum (focal OR generalized)Narrow-spectrum (primarily focal, not exclusive)
ValproateCarbamazepine / Oxcarbazepine
LevetiracetamPhenytoin
LamotriginePhenobarbitone
TopiramateLacosamide
ClobazamGabapentin / Pregabalin

6.5 Individual ASM — High-Yield Details

PropertyDetail
MechanismBlock voltage-dependent Na channel
EfficacyEffective for partial or generalized seizure, but can aggravate absence/myoclonic seizures
PharmacologyCYP enzyme INDUCER → significant interactions with other ASMs, warfarin, DOAC, Rifampicin, Isoniazid, theophylline, prednisolone, haloperidol, OC pills
SpecialInduces own metabolism → need to increase dose after 1st month (autoinduction)
Pharmacogenetic safetyScreen HLA-B*15:02 before first exposure in people with ancestry from genetically at-risk populations; a positive result strongly predicts carbamazepine-associated SJS/TEN, so use an alternative in a carbamazepine-naïve patient. HLA-A*31:01 is associated with a broader range of carbamazepine hypersensitivity reactions [20]
Side effectsDizziness, somnolence, rash, SJS, hyponatremia, cardiac arrhythmia, marrow suppression, hepatitis

PropertyDetail
MechanismBlock voltage-dependent Na channel
EfficacyEffective for partial/generalized; aggravates absence/myoclonic
PharmacologyCYP enzyme inducer; hepatic P450 metabolism → enzyme saturable → zero-order kinetics
Therapeutic windowNear enzyme saturation point → small change in dose may lead to dramatic change in drug concentration
Protein bindingHighly protein bound → low serum protein can change concentration of unbound fraction
Clinical useIV phenytoin/fosphenytoin is one second-line option after adequate benzodiazepine treatment in convulsive status epilepticus; it is not the first-line abortive drug [21]
Side effectsDizziness, somnolence, rash, dose-related neurotoxicity (nystagmus, unsteady gait), gingival hyperplasia, coarsening facial features, hirsutism, hepatitis, hypocalcemia (impairs Vit D absorption), low folate

Phenytoin Zero-Order Kinetics — Why It Matters

Most drugs follow first-order kinetics (constant fraction eliminated per unit time). Phenytoin saturates its metabolizing enzyme at therapeutic doses, so it switches to zero-order kinetics (constant AMOUNT eliminated per unit time). This means a small dose increase can cause a disproportionately large rise in serum level → toxicity. This is why phenytoin requires therapeutic drug monitoring. [1]

PropertyDetail
MechanismMultiple: Na channel, GABA, Ca currents
EfficacyEffective for focal OR generalized seizures (broad-spectrum)
PharmacologyLiver metabolism; CYP enzyme INHIBITOR; highly protein bound
Reproductive safetyMajor congenital and neurodevelopmental risks with fetal exposure. Do not prescribe automatically by sex or age: discuss pregnancy potential and follow current jurisdiction-specific valproate safety measures, specialist review and pregnancy-prevention requirements [17]
Side effectsDizziness, somnolence, tremor, weight gain, hyperammonemia, hepatitis, pancreatitis, impaired platelet function

PropertyDetail
MechanismBlock voltage-dependent Na channel
EfficacyEffective for focal or generalized seizures
PharmacologyHepatic metabolism, excreted in urine; few drug interactions
Reproductive contextOften considered because pregnancy data are more reassuring than for valproate, but choice still depends on seizure type, interactions and the individual's reproductive plans [17]
TitrationSlow in action, gradual titration every 2 weeks → reduce incidence of cutaneous S/E
Side effectsRash (5-10%), SJS, dizziness, somnolence, tremor, nausea
CounselingWarn patient of rash, and stop ASAP and seek medical advice if rash occurs

PropertyDetail
MechanismActs through synaptic vesicle proteins → modulate exocytotic function
EfficacyEffective for focal or generalized seizures
PharmacologyPartially metabolized by enzymatic hydrolysis, NOT dependent on P450 system; drug and metabolite excreted in urine
Favored in patients with liver impairment
Few drug interactions
Side effectsDizziness, somnolence, mood/psychiatric (hostility, depression, anxiety)

Factors: Drug effectiveness (focal vs. generalized), potential adverse effects, childbearing plans, drug interactions, comorbid medical conditions (hepatic/renal disease), patient preference, cost. [1]

ScenarioBest ChoiceAvoid
Generalized epilepsy (e.g., JME)Syndrome-appropriate broad-spectrum ASM; levetiracetam/lamotrigine are common options and valproate may be most effective for some syndromes but is tightly safety-restrictedPhenytoin, Carbamazepine may worsen myoclonus/absence
Childhood absenceEthosuximide—
Pregnancy possible or plannedPreconception epilepsy-specialist review; lamotrigine or levetiracetam are often preferred when suitableValproate and topiramate require strict current safety measures; never stop an effective ASM abruptly [17]
Liver impairmentLevetiracetamHepatically metabolized ASMs
Psychiatric comorbidity—Levetiracetam (mood/psychiatric S/E)
Enzyme inducers—Note: CBZ, PHT, phenobarbital are inducers (interact with warfarin, DOAC, OC pills, Rifampicin, Isoniazid)
Enzyme inhibitor—Note: Valproate is an inhibitor

Response to 1st ASM: ~50%. Response to 2nd ASM: additional ~15%. Response to 3rd ASM or multiple drug: additional ~5%. [1]

Drug-resistant/refractory epilepsy: 1/3 of patients. Defined as failed to become seizure free with adequate trial of TWO antiseizure medications (either monotherapy or combination). [1]

6.8 Surgical Management

Highly selected patients with epileptic foci identified. Extensive workup and surgical planning. Localization + Functional impact of resection.

Classical example: Anterior temporal lobectomy or hippocampectomy for hippocampal sclerosis → 60-70% seizure freedom rates vs. 0-10% on medical Rx. [1]

Complications: surgical (infection, visual field defect, hemiparesis), memory impairment. [1]

Wire to send impulse to vagus nerve. Exact mechanism uncertain — altered activities in RAS, central autonomic network, limbic system, noradrenergic projection network. Reduces frequency and duration of seizure. 'Palliative' — in theory cannot achieve seizure freedom. [1]


Part 7: Status Epilepticus

Treat a convulsive seizure lasting 5 minutes, or recurrent seizures without recovery to baseline between events, as convulsive status epilepticus. Persistent impaired consciousness after convulsions stop also raises concern for non-convulsive status and should prompt urgent EEG when available. [1][21]

MEDICAL EMERGENCY. Do not wait for an hour: time and treat from the 5-minute threshold while managing ABC, glucose and reversible causes. Longer duration reduces the probability of medication response. [1][21]

Acute cerebral insult: CNS infection (e.g., HSV encephalitis), autoimmune encephalitis, stroke, brain tumor, metabolic encephalopathy. Withdrawal/Stop ASM. [1]

StageCurrent-safe principle
Immediate stabilizationCall for emergency/airway support; protect from injury, position and suction as appropriate, give oxygen if needed, monitor ECG/BP/SpO₂, obtain IV/IO access, check bedside glucose and treat hypoglycemia immediately; send targeted tests and treat the precipitant
First lineGive an adequate dose of a benzodiazepine by the route available under the local protocol; if the seizure persists, one repeat dose is commonly recommended. Underdosing is a frequent reason for apparent failure
Second line after 2 benzodiazepine dosesGive one IV loading option: levetiracetam, phenytoin/fosphenytoin, or sodium valproate. Choice depends on contraindications, interactions, pregnancy potential and the local formulary; NICE notes levetiracetam may be quicker to administer and have fewer adverse effects [21]
RefractoryUrgent ICU/anaesthetic and neurology management, airway control and continuous EEG; follow the institutional refractory-status protocol for anaesthetic infusion

Do Not Use the Slide Flowchart as a Bedside Prescription

The 2024 slide flowchart shows a lecture-era adult example (lorazepam/midazolam/diazepam, then phenytoin or valproate). Drug availability, exact doses and contraindications are protocol- and patient-specific, and current guidance also includes IV levetiracetam as a second-line option. Use the current local emergency chart. [1][21]

Close neuro-observation. Consider ICU admission. Ensure ABC. Prompt initiation of ASM. Continuous EEG monitoring. Workup and treat possible underlying cause (tumor, infection, CNS infection, autoimmune encephalitis, metabolic). Prevent complications. [1]

Status Epilepticus — SAQ Framework

When asked to manage status epilepticus in an SAQ: (1) time the seizure, call for help and manage ABC; (2) check bedside glucose and treat hypoglycemia without delay (give thiamine promptly as well if at risk); (3) first-line benzodiazepine; (4) after 2 adequate benzodiazepine doses, one IV second-line agent—levetiracetam, phenytoin/fosphenytoin or valproate; (5) refractory status → ICU/anaesthesia + continuous EEG; (6) identify and treat the underlying cause; (7) prevent systemic complications. [1][13][21]


Part 8: Brain Death

Brain death = brainstem death = irreversible cessation of brainstem function. Despite philosophical arguments, brain death = death legally in common law jurisdiction. After certified brain death, patient is medically certified dead. [1]

Brain death is diagnosed when there is: (1) Severe, irreversible brain injury (patient in coma, usually confirmed with neuroimaging); (2) Exclusion of potentially reversible causes; (3) Absent brainstem reflexes. [1]

Current Hong Kong guidance (2023): all preconditions must remain satisfied through a minimum 4-hour observation period before the first formal examination. The total observation period is extended to 24 hours for hypoxic-ischaemic encephalopathy after cardiorespiratory arrest. After targeted temperature management below 35°C for more than 6 hours, testing is generally delayed until 24 hours after rewarming to ≥36°C, with longer delay considered after deeper hypothermia or prolonged sedatives. [22]

Certification requires two separate examinations, each by a different medical practitioner. One must be a designated specialist (usually intensive care/critical care, neurology or neurosurgery); the other should preferably have the same qualification and must be at least 6 years after registration with the required skill and knowledge. The transplant retrieval team must not determine brainstem death. [22]

Before testing brainstem reflexes, you MUST confirm: [1]

  1. Irreversible severe brain injury
  2. Neuromuscular function is intact (no paralytic agents)
  3. Absence of depressant drugs
  4. Absence of reversible causes contributing to comatose state
  5. Ensure normothermic, correct metabolic/electrolyte disturbance, stable hemodynamic

The 2023 Hong Kong guideline makes the prerequisites operational: the patient must be apnoeic and mechanically ventilated; exclude lingering sedatives/poisons and neuromuscular blockade (confirm intact neuromuscular conduction); core temperature should be > 35°C; and major metabolic/endocrine derangements and hypotension (SBP ≤90 mmHg or MAP ≤60 mmHg) must not confound the examination. These notes are a conceptual summary, not a certification checklist—use the hospital form and current HKSCCM guidance. [22]

Reversible Causes to Exclude Before Brain Death Testing

From lecture and supporting context [1][2]: (1) Primary hypothermia; (2) Hypoglycemia; (3) Electrolyte/endocrine disturbance; (4) Muscle relaxants/neuromuscular blocking agents; (5) Barbiturate/sedative overdose; (6) Alcohol intoxication; (7) Depressant drug effects. If ANY of these are present, you CANNOT proceed with brain death testing.

TestWhat You're Testing
No pupillary responseCN II, III
No corneal reflexCN V (afferent), VII (efferent)
No vestibulo-ocular reflex (cold caloric test)CN VIII (afferent), III/VI (efferent)
No motor response in cranial or somatic distribution to adequate pain within trigeminal distributionTests brainstem-mediated response; spinal reflex movements outside cranial-nerve distribution may still occur
No gag and cough reflexCN IX, X
No respiratory movement with apnea testPerformed last under a controlled protocol; current HK threshold requires PaCO₂ > 60 mmHg and pH < 7.30 (or a > 20 mmHg PaCO₂ rise above baseline in chronic hypercapnia), with abandonment if safety cannot be maintained [22]

Objective demonstration of absent intracranial blood flow is required when clinical preconditions cannot be satisfied or brainstem testing is incomplete—for example unclear cause, possible metabolic/drug confounding, cranial nerves cannot be tested, cervical cord injury, or cardiovascular/respiratory instability precluding apnoea testing. A confirmatory study does not make an elicitable brainstem response acceptable. [22]

Accepted Hong Kong examples: four-vessel digital-subtraction angiography showing absent vertebrobasilar and supratentorial intracranial flow, or radionuclide perfusion imaging/SPECT with a tracer that crosses the blood-brain barrier. [22]


The lecture defines altered mental state/delirium as any acute change in attention/awareness or cognition [1]. Key features from supporting material [2]:

  • Acute onset with fluctuating course (hallmark)
  • Impaired attention (cardinal feature — test with serial 7s, digit span)
  • Disturbed sleep-wake cycle
  • Perceptual disturbances (visual hallucinations common)
  • Hyperactive vs. hypoactive vs. mixed subtypes

Delirium vs. Dementia: Delirium is acute with fluctuating attention; dementia is chronic with preserved attention early on. But they frequently co-exist — 2/3 of delirium occurs in patients with underlying dementia. [2]

From GC 051: Anti-NMDA receptor encephalitis — most commonly affects young women and children, associated with ovarian teratomas. Presents with: viral prodrome → neuropsychiatric symptoms → abnormal movements (orofacial/limb dyskinesias) → seizures → altered consciousness → autonomic dysfunction.

From supporting material: West Haven Criteria grades 0-4. Grade 2+ = asterixis (flapping tremor). Mechanism: ↑ ammonia crosses BBB → astrocyte swelling → cerebral edema. Management: lactulose, rifaximin, treat precipitants.


High Yield Summary

  1. Consciousness: = Arousal (brainstem ARAS) + Awareness (cortex). Coma requires damage to ARAS or diffuse bilateral cortical dysfunction. A low GCS prompts urgent airway assessment; airway protection is a clinical decision, not a number alone.

  2. Syncope vs. Seizure

    • Witness history is king. Syncopal myoclonus occurs in 20% of syncope — don't misdiagnose as seizure. Cardiac syncope mortality >> seizure mortality.
  3. Seizure Classification

    • The slide uses ILAE 2017; ILAE 2025 uses focal, generalized, unknown and unclassified, with preserved/impaired consciousness. Epilepsy = ≥2 unprovoked seizures > 24h apart, OR one + ≥60% 10-year recurrence probability, OR an epilepsy syndrome.
  4. Epilepsy Syndromes

    • MTLE-HS (epigastric aura, automatisms, often drug-resistant) and JME (morning myoclonus → GTCS, 3-5.5 Hz spike-wave, avoid CBZ/PHT).
  5. ASM Choice

    • Match spectrum to syndrome and individualize for interactions, psychiatric/renal/hepatic disease and reproductive plans. Valproate/topiramate safety rules are current and jurisdiction-specific. Screen HLA-B*15:02 before first carbamazepine exposure in genetically at-risk ancestry.
  6. Status Epilepticus

    • Treat convulsive seizure at 5 minutes: adequate benzodiazepine → one IV second-line agent (levetiracetam, phenytoin/fosphenytoin or valproate) → ICU/anaesthetic protocol if refractory. Persistent impaired consciousness may require urgent EEG.
  7. Brain Death

    • In Hong Kong, follow the 2023 HKSCCM brainstem-death protocol: defined observation period, preconditions and exclusions, two separate examinations by qualified doctors, all specified responses absent, and blood-flow testing when the clinical route is incomplete/confounded.

Active Recall - Seizure, LOC, Epilepsy, Brain Death

[1] Lecture slides: GC 081. Seizure and loss of consciousness Delirium and encephalopathy; epilepsy; coma and brain death; care of unconscious patients; electrophysiology I.pdf [2] Senior notes: Ryan Ho Neurology.pdf (Section 4.1.2 Coma and Persistent Loss of Consciousness; Section 4 Disturbances in Consciousness and Epilepsy) [3] Senior notes: Maksim Medicine Notes.pdf (Section: Status Epilepticus Management) [4] Medicine lecture slides: GC_Interactive tutorial (Neuro-Epilepsy case) student copy.pdf [5] Lecture slides: GC 051. Fever and confusion_meningitis and encephalitis; suppurative brain infection.pdf (Autoimmune Encephalitis) [6] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Hepatic encephalopathy) [7] Senior notes: Ryan Ho Fundamentals.pdf (Section 3.4.4 Faints and Fits; Section 3.4.5 Delirium) [8] Senior notes: Ryan Ho Cardiology.pdf (Section 2.4 Syncope) [9] Senior notes: Ryan Ho Diagnostic Radiology.pdf (Brain death confirmation — empty light bulb sign) [10] Past papers: 2019 Fourth Summative SAQ.pdf (Q8: GCS calculation, brain herniation; Q10: fever and confusion with seizure) [11] Past papers: 2021 Fourth Summative Assessment MCQ.pdf (Q41: seizure in context of stroke) [12] American Academy of Neurology, American Congress of Rehabilitation Medicine, and NIDILRR: Practice guideline update—Disorders of consciousness [13] South African National Department of Health: Adult Hospital Level Standard Treatment Guidelines—Neurological disorders (2025) [14] ACC/AHA/HRS: 2017 guideline for the evaluation and management of syncope [15] International League Against Epilepsy: Updated classification of epileptic seizures (2025) [16] International League Against Epilepsy: A practical clinical definition of epilepsy [17] NICE NG217: Principles of treatment, safety, monitoring and withdrawal [18] NICE NG217: Diagnosis and assessment of epilepsy [19] Hong Kong Transport Department: Medical fitness requirements for driving licences [20] Clinical Pharmacogenetics Implementation Consortium: HLA genotype and carbamazepine/oxcarbazepine guideline [21] NICE NG217: Treating status epilepticus, repeated or cluster seizures, and prolonged seizures [22] Hong Kong Society of Critical Care Medicine: Guidelines on certification of death following irreversible cessation of brainstem function, 5th ed. (2023)

On this page

No Headings